Core Viewpoint - The stock of Baiaosaitu-B (02315) has seen a significant increase, reaching a new historical high of 44 HKD, with a current price of 42.50 HKD, reflecting a rise of 7.59% and a trading volume of 85.6693 million HKD [1][6]. Group 1 - On January 9, Baiaosaitu announced a licensing agreement with Yushibo to systematically evaluate the bispecific antibody-drug conjugate (BsADC) projects, aiming to accelerate the development of bispecific antibody dual-drug conjugates (BsAD2C) [1][6]. - The agreement grants Yushibo an option for global exclusive licensing of two BsADC projects from Baiaosaitu [1][6]. - Baiaosaitu is entitled to receive an upfront payment for the option, and upon Yushibo exercising the option, Baiaosaitu will receive additional payments including option exercise fees, development and regulatory milestone payments, commercialization milestone payments, and sales royalties [1][6].
百奥赛图-B盘中涨超11%再创新高 公司与育世博达成进一步合作